Related Experiment Videos
Manchester regional breast study--5 and 10 year results
The British Journal of Surgery
|December 1, 1982
Summary
Postoperative radiotherapy significantly reduced local recurrence in early breast cancer patients (Stage I) after simple mastectomy. However, survival rates were similar between radiotherapy and no-radiotherapy groups for both Stage I and Stage II breast cancer.
Area of Science:
- Oncology
- Surgical Oncology
- Radiation Oncology
Background:
- Early breast cancer management has evolved, with surgical techniques and adjuvant therapies playing crucial roles.
- The efficacy of postoperative radiotherapy in reducing local recurrence and improving survival in early-stage breast cancer remains a key area of investigation.
Purpose of the Study:
- To evaluate the impact of postoperative radiotherapy on survival and local recurrence rates in patients with early breast cancer (Clinical Stage I and II).
Main Methods:
- A prospective clinical trial involving 1022 early breast cancer patients treated between 1970 and 1975.
- Clinical Stage I patients were randomized to simple mastectomy with or without postoperative radiotherapy.
- Clinical Stage II patients were randomized to simple mastectomy with postoperative radiotherapy or radical mastectomy alone.
Main Results:
- For Clinical Stage I breast cancer, postoperative radiotherapy significantly reduced local recurrence frequency compared to simple mastectomy alone, with no significant difference in overall survival.
- For Clinical Stage II breast cancer, no statistically significant differences in survival or local recurrence were observed between simple mastectomy with postoperative radiotherapy and radical mastectomy alone.
Conclusions:
- Early postoperative radiotherapy is effective in reducing local recurrence for Stage I breast cancer patients undergoing simple mastectomy.
- The addition of postoperative radiotherapy to simple mastectomy or radical mastectomy did not significantly impact survival rates for Stage I or Stage II breast cancer in this cohort.